2024 Annual Meeting | S24 - Epilepsy Clinical Syndromes and Management

Date Tuesday 04/16/24

Time 03:30 PM - 05:30 PM MDT Add To Calendar

Location Colorado Convention Center | Bluebird 3E-H

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Scientific Platform Session

Moderator(s) Sasha Alick-Lindstrom, MD, FACNS, FAES, FAAN, Meriem K. Bensalem Owen, MD

Topic(s) Epilepsy/Clinical Neurophysiology (EEG)

Learning Objectives A group of abstracts covering a similar topic will be presented in an eight-minute oral format followed by four minutes for question and answer with the author.

CME Available 2.00 CME credits

Program Materials Program Evaluations

Event Timeline
03:30 PM - 03:42 PM MDT	Abstract	001 - Long-term Clinical Outcome of Cryptogenic New-onset Refractory Status Epilepticus (C-NORSE) Patients Yoonhyuk Jang, MD, PhD
03:42 PM - 03:54 PM MDT	Abstract	002 - Does Treatment-resistant Epilepsy Get Better or Worse Over Time? Ojas Potnis
03:54 PM - 04:06 PM MDT	Abstract	003 - Cardiac Biomarkers for SUDEP: Retrospective Evaluation of Nine Patients with EMU Admissions Alejandra Duque Ramirez, MD
04:06 PM - 04:18 PM MDT	Abstract	004 - Effects of Depression on Clinical Outcomes in Cognitively Impaired Patients with Epilepsy Jiping Zhou, MD, MPH
04:18 PM - 04:30 PM MDT	Abstract	005 - Acute Postictal Changes in Mood Amit Ahituv
04:30 PM - 04:42 PM MDT	Abstract	006 - Autism Spectrum Disorder in Children with Infantile Epileptic Spasms: Prevalence and Risk Factors Aria F. Terango
04:42 PM - 04:54 PM MDT	Abstract	007 - Assessing the Clinical and Treatment Landscape of Genetic Epilepsies Through 3,760 Individuals Julie Xian
04:54 PM - 05:06 PM MDT	Abstract	008 - Factors Associated with Frequent Emergency Visits for Seizure/Epilepsy: A Multi-state Analysis Uma Sarwadnya
05:06 PM - 05:18 PM MDT	Abstract	009 - Emergency Department Treatment of Alcohol-associated Seizures in Detroit: A Multicenter Retrospective Study Tabassum Chowdhury
05:18 PM - 05:30 PM MDT	Abstract	010 - Disparities in Epilepsy Surgery for Medically Refractory Epilepsy: Insights from the National Inpatient Sample Database (2016-2019) Prabandh R. Buchhanolla, MBBS

Faculty Disclosures
Sasha Alick-Lindstrom, MD, FACNS, FAES, FAAN	Dr. Alick-Lindstrom has nothing to disclose.
Meriem K. Bensalem Owen, MD	The institution of Dr. Bensalem Owen has received research support from Xenon. The institution of Dr. Bensalem Owen has received research support from UCB. The institution of Dr. Bensalem Owen has received research support from NeuroPace.
Lakshmi S. Amaravadi, PhD	No disclosure on file
Amit Ahituv	Ms. Ahituv has nothing to disclose.
Maria Pleshkevich	No disclosure on file
Claude Steriade, MD	The institution of Dr. Steriade has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for The Epilepsy Study Consortium. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Steriade has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for DOJ. The institution of Dr. Steriade has received research support from NIH. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Epitel. Dr. Steriade has received personal compensation in the range of $500-$4,999 for serving as a Consultant with Jazz Pharmaceuticals.
Anureet Kaur	No disclosure on file
Eden Tefera, BS	Ms. Tefera has nothing to disclose.
	No disclosure on file
Brad K. Kamitaki, MD	Dr. Kamitaki has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brown and Brown Absence Services Group. The institution of Dr. Kamitaki has received research support from American Epilepsy Society. The institution of Dr. Kamitaki has received research support from New Jersey Health Foundation.
Uma Sarwadnya	Miss Sarwadnya has nothing to disclose.
Leila Alidoost	No disclosure on file
Jennifer Geller	No disclosure on file
Kylie Getz	No disclosure on file
Jennifer Dai, MD	Ms. Dai has nothing to disclose.
Alejandra Duque Ramirez, MD	Dr. Duque Ramirez has nothing to disclose.
Asra Tanwir, MD, MBBS	Dr. Tanwir has nothing to disclose.
Charles A. Szabo, MD, FAAN	Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation of Central and South Texas. Dr. Szabo has received personal compensation in the range of $0-$499 for serving as a Reviewer with NINDS.
Irwin Hollander, PhD	No disclosure on file
Soo Hyun Ahn, MD	Dr. Ahn has nothing to disclose.
Yoonhyuk Jang, MD, PhD	Mr. Jang has nothing to disclose.
Su Yee Mon	No disclosure on file
Han Sang Lee	No disclosure on file
Kon Chu	No disclosure on file
Sang Kun Lee, MD	Prof. Lee has nothing to disclose.
Soon-Tae Lee, MD, PhD	Prof. Lee has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Advanced Neural Technologies. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Prof. Lee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Celltrion. The institution of Prof. Lee has received research support from Roche. The institution of Prof. Lee has received research support from Celltrion. Prof. Lee has received intellectual property interests from a discovery or technology relating to health care.
Kyung Il Park	No disclosure on file
Ji Hye You, NP	Ms. YOU has nothing to disclose.
Jiping Zhou, MD, MPH	Dr. Zhou has nothing to disclose.
Rohit A. Marawar, MD, FAAN	Dr. Marawar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Pharma. The institution of Dr. Marawar has received research support from Catalyst Pharma.
Tabassum Chowdhury	Ms. Chowdhury has nothing to disclose.
Melissa Ly	Miss Ly has nothing to disclose.
Jason Liu	Mr. Liu has nothing to disclose.
Shatha Wahbi	Ms. Wahbi has nothing to disclose.
Manik Tetarbe, MD	Dr. Tetarbe has nothing to disclose.
Maysaa M. Basha, MD	Dr. Basha has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai.
Deepti Zutshi, MD, FAAN	Dr. Zutshi has nothing to disclose.
Gabriel Biondo	Mr. Biondo has nothing to disclose.
Rachel Sukonnik	No disclosure on file
Caitlin Grzeskowiak	No disclosure on file
Gary R. Cutter, PhD	Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biodelivery Sciences International, Biogen, Click Therapeutics, Genzyme, Genentech, GW Pharmaceuticals, Immunic, Klein-Buendel Incorporated, Medimmune/Viela Bio, Medday, Merck/Serono, Neurogenesis LTD, Novartis, Osmotica Pharmaceuticals, Perception Neurosciences, Recursion/Cerexis Pharmaceuticals, Regeneron, Reckover Pharmaceuticals, Roche, TG Therapeutics.. Dr. Cutter has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics, AI therapeutics, AMO Pharma, Astra-Zeneca, Avexis Pharmaceuticals, Biolinerx, Brainstorm Cell Therapeutics, Bristol Meyers Squibb/Celgene, CSL Behring, Galmed Pharmaceuticals, Green Valley Pharma, Horizon Pharmaceuticals, Immunic, Karuna Therapeutics, Mapi Pharmaceuticals LTD, Merck, Mitsubishi Tanabe Pharma Holdings, Opko Biologics,Prothena Biosciences, Novartis, Regeneron, Sanofi-Aventis, Reata Pharmaceuticals, NHLBI (Protocol Review Committee), University of Texas Southwestern, University of Pennsylvania, Visioneering Technologies, Inc.. Dr. Cutter has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JASN.
Jacqueline French, MD, FAAN	Dr. French has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation. The institution of Dr. French has received research support from Epilepsy Study Consortium/ Epilepsy Foundation (Funded by UCB). The institution of Dr. French has received research support from GW/One8 Foundation/FACES. The institution of Dr. French has received research support from NINDS. The institution of Dr. French has received research support from Xenon. The institution of Dr. French has received research support from Cerevel. The institution of Dr. French has received research support from FACES. The institution of Dr. French has received research support from UCB. The institution of Dr. French has received research support from Epilepsy Study Consortium. The institution of Dr. French has received research support from UCB. Dr. French has received personal compensation in the range of $100,000-$499,999 for serving as a Chief Medical/Innovation Officer with Epilepsy Foundation. Dr. French has a non-compensated relationship as a Consultant with Angelini that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Alterity Therapeutics Limited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Bright minds Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerecin Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cognizance Biomarkers that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Arvelle that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Beacon biosignals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Advisory Board with Biohaven Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Bloom Science Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with BridgeBio Pharma Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant, scientific advisory board with Camp4 Therapeutics Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, Scientific Advisory Board with Cerebral Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Cerevel that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Coda Biotherapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Genentech Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Crossject that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eisai, that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Eliem Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Encoded Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with iQure Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Engrail that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epihunter that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a SAB with Epiminder that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Epitel Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Equilibre BioPharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Greenwich Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Grin Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with GW Pharma that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Janssen Pharmaceutica that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Jazz Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Knopp Biosciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Lipocine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with LivaNova that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Longboard Pharmaceuticals that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Lundbeck that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Marinus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Modulight Bio that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Leal therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neumirna Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant,SAB with Neurocrine that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuroelectrics USA Corporation that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Neuronetics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ono Pharmaceutical Co that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Otsuka Pharmaceutical Development that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with Ovid Therapeutics Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Paladin Labs Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Rapport Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Praxis that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with PureTech LTY Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with SK Life Sciences that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Stoke that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Supernus that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Takeda that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant, SAB with UCB Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Ventus Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting, steering committee with Xenon that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consultant with Korro Bio Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with NeuroPro Therapeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Receptor that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory board with Sage Therpeutics that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Advisory Board with Third Rock Ventures that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consultant with Vida Ventures Management that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Pfizer that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Agrithera, Inc that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a consulting with Autifony therapeutics, Unlimited that is relevant to AAN interests or activities. Dr. French has a non-compensated relationship as a Consulting with Baergic Bio that is relevant to AAN interests or activities.
Ojas Potnis	Mr. Potnis has nothing to disclose.
Joseph Medina	No disclosure on file
Eda Coban	No disclosure on file
Aria F. Terango	No disclosure on file
Lauren Waldron, MD	Dr. Waldron has nothing to disclose.
Shaun Hussain, MD	Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MGC Pharma. Dr. Hussain has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zogenix. Dr. Hussain has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Grenwich Biosciences.
David Tabibzadeh	No disclosure on file
Norah Gidanian	No disclosure on file
Rujuta Sathe	No disclosure on file
Emmi Deckard	No disclosure on file
Rajsekar R. Rajaraman, MD	Dr. Rajaraman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Marinus Pharmacueticals.
Hiroki Nariai, MD	Dr. Nariai has nothing to disclose.
Ritesh Ramdhani, MD	Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Accorda. Dr. Ramdhani has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal. The institution of Dr. Ramdhani has received research support from NIH. Dr. Ramdhani has received research support from Parkinson Alliance.
Julie Xian	No disclosure on file
Michael Kaufman	No disclosure on file
Sarah Ruggiero	No disclosure on file
Mark Ramos	No disclosure on file
Alexander Gonzalez	No disclosure on file
Amanda Back	No disclosure on file
Lea Bailey-Medley	No disclosure on file
Stacey Cohen	No disclosure on file
Vishnu A. Cuddapah, MD	The institution of Dr. Cuddapah has received research support from NIH. The institution of Dr. Cuddapah has received research support from CURE Epilepsy.
Colin A. Ellis, MD	Dr. Ellis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Epiminder.
Natalie Ginn	No disclosure on file
Naomi Lewin, MD	Dr. Lewin has nothing to disclose.
Laina Lusk	No disclosure on file
Eric D. Marsh, MD, PhD	Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmacuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from NIH. The institution of Dr. Marsh has received research support from Rett Syndrome Research Trust. The institution of Dr. Marsh has received research support from International Rett Syndrome Foundation. The institution of Dr. Marsh has received research support from Eagles Autism Challenge. The institution of Dr. Marsh has received research support from LouLou Foundation. The institution of Dr. Marsh has received research support from International CDKL5 Resarch Foundation. The institution of Dr. Marsh has received research support from Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from Marinus. The institution of Dr. Marsh has received research support from Stoke Therapeutics. The institution of Dr. Marsh has received research support from Takeda Pharmaceuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Grant Review with NIH. Dr. Marsh has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Witness with Department of Human Services. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Medscape.
Shavonne Massey, MD	Dr. Massey has a non-compensated relationship as a consultant with Sun Pharmaceutical Ltd that is relevant to AAN interests or activities.
Xilma R. Ortiz-Gonzalez, MD, PhD	The institution of Dr. Ortiz-Gonzalez has received research support from Robert Wood Johnson Foundation . The institution of Dr. Ortiz-Gonzalez has received research support from NINDS.
Pamela Pojomovsky McDonnell, MD	Dr. Pojomovsky McDonnell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Connected Research. Dr. Pojomovsky McDonnell has received research support from AAN.
Katie Rose Sullivan	No disclosure on file
Katherine Taub	No disclosure on file
Sarah F. Tefft	Ms. Tefft has nothing to disclose.
Katherine Helbig	No disclosure on file
Ethan M. Goldberg, MD, PhD	Dr. Goldberg has nothing to disclose.
Ingo Helbig	No disclosure on file
Mark P. Fitzgerald, MD, PhD	Dr. Fitzgerald has nothing to disclose.
Michelle Fabian, MD, FAAN	Dr. Fabian has nothing to disclose.
Monika Thapa, MBBS	Dr. Thapa has nothing to disclose.
Abdullahi Musa Adamu, MBBS	Dr. Adamu has nothing to disclose.
Mostafa Hotait, MD	Dr. Hotait has nothing to disclose.
Roohi Katyal, MD	Dr. Katyal has nothing to disclose.
Vijayakumar Javalkar, MD, FAAN	Dr. Javalkar has nothing to disclose.
Prabandh R. Buchhanolla, MBBS	Dr. Buchhanolla has nothing to disclose.
Lakshmi Chandaluri	No disclosure on file
Saurabh Kataria, MD	Dr. Kataria has nothing to disclose.